TGFB1 and neoplasm: Considering the immunosuppressive functions of TGF-β in advanced tumors, the combination of Nf18001 and YM101 holds promise as a comprehensive strategy to enhance anti-tumor immune responses and possibly promote T cell infiltration into tumor centers.